Dapagliflozin plus metformin improved glycemic control, weight loss

June 26, 2010

ADA 70th Scientific Sessions ORLANDO — Dapagliflozin, an investigational selective sodium-glucose cotransporter-2 inhibitor, improved HbA1c levels and induced further weight loss in combi...

FDA approves liraglutide to treat type 2 diabetes

January 26, 2010

The FDA has approved liraglutide, the first once-daily human glucagon-like peptide-1 analog for the treatment of type 2 diabetes. Liraglutide is intended as an adjunct to diet and exercise to im...

Risks outweighed benefits of darbepoetin alfa in patients with type 2 diabetes, CKD, anemia

December 1, 2009

Renal Week 2009Darbepoetin alfa did not decrease the risk for death, cardiovascular or renal events in patients with type 2 diabetes, chronic kidney disease and moderate anemia enrolled in the T...

Consensus group suggested ‘remission’ not ‘cure’ as accurate term in diabetes

November 6, 2009

It may be more accurate to use the term remission rather than cure for chronic diseases such as diabetes, a consensus group concluded. “Defining remission or cure of diabetes is not as strai...

Therapeutic advantages of saxagliptin, the newest DPP-IV inhibitor on the market

November 1, 2009

Saxagliptin was approved by the FDA in July and represents the second DPP-IV inhibitor to reach the U.S. market for the treatment of type 2 diabetes. DPP-IV is the enzyme responsible for the rap...

AACE, ACE release new algorithm for patients with type 2 diabetes

October 23, 2009

The American Association of Clinical Endocrinologists and American College of Endocrinology have developed a new algorithm for the management of patients with type 2 diabetes. The algo...

Nephropathy associated with allergies in men with type 2 diabetes

October 8, 2009

Allergies may be associated with microalbuminuria in men with type 2 diabetes, new data suggest. “Allergy is a common disease that is increasing worldwide, so our findings may have important...

Weight loss resolved obstructive sleep apnea in obese patients with type 2 diabetes

September 29, 2009

Weight loss as a result of an intensive lifestyle intervention significantly improved obstructive sleep apnea among obese patients with type 2 diabetes, according to recent data from the Sleep A...

Sex hormone-binding globulin levels predicted type 2 diabetes risk in women, men

September 23, 2009

Low circulating levels of sex hormone-binding globulin are a strong predictor for type 2 diabetes in both women and in men. Because it is uncertain whether circulating sex hormone-binding glob...

Empower the patient

September 18, 2009

I have prescribed insulin either alone or as an adjunct to oral medication for a number of my patients with type 2 diabetes. Most of them are receiving long-acting insulin, either glargine (Lantus, S...